Dual-Diagnosis and Compulsory Treatment

Substance-Related Disorders Clinical Trial

Official title:

Compulsory Treatment of Alcohol and Drug Dependent Patients and Dual Diagnosis in 5 Counties of Health Region South-East, Norway

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00970372
• Other study ID #: SSHF_815360
• Status: Completed
• Phase: N/A
• First received: September 1, 2009
• Last updated: April 15, 2014
• Start date: September 2008
• Est. completion date: May 2012

Study information

• Verified date: April 2014
• Source: Sorlandet Hospital HF
• Contact: n/a
• Is FDA regulated: No
• Health authority: Norway: Directorate of Health
• Study type: Observational

Clinical Trial Summary

The Norwegian Social and Welfare Act of 1992, opened for compulsory commitment of patients with serious alcohol and drug problems to inpatient care. Clinical research of compulsory committed dual diagnosed patients is to date unavailable and is demanded by the health authorities of Norway. Because there has been limited examination/screening and no post-treatment research efforts on this group of patients, the investigators have limited knowledge of the treatment as well as the patient group. Do compulsory treated patients differ from those voluntarily admitted? Does this type of treatment influence the patients' motivation to change their behaviour, and does the treatment effort lead to positive outcome effects in the long run?

The primary aim is to acquire new and in depth descriptive knowledge about the compulsory treated group of patients according to: Drug dependence, psychiatric and somatic co-morbidity and socio-demographic characteristics, and investigate whether the treatment yields the intended outcomes in terms of improved substance abuse measures.

A second aim is to compare the group with a corresponding group of voluntarily admitted patients within the same wards. A follow-up interview focusing on motivational issues within 6 months post treatment to evaluate the long-term results of the treatment is planned.

A quasi-experimental, prospective case-control study will be conducted. Compulsory committed patients in five counties during a two year period, will be compared to a group of voluntarily admitted patients. The groups will be compared regarding 1) description and screening 2) motivation to change and 3) outcome results after 6 months.

Both official authorities as well as clinical practitioners would benefit from valid Norwegian results and knowledge within this field to form further policies and evidence based best practice for this vulnerable group of patients.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 202
• Est. completion date: May 2012
• Est. primary completion date: May 2012
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients with alcohol and substance use disorders

• Estimated premorbid IQ of 70 or higher

Exclusion Criteria:

• Active drug or alcohol abuse

Study Design

Time Perspective: Prospective

Related Conditions & MeSH terms

• Dual Diagnosis
• Substance-Related Disorders

Locations

Country	Name	City	State
Norway	Sorlandet Hospital	Kristiansand	Vest Agder

Sponsors (1)

Lead Sponsor	Collaborator
Sorlandet Hospital HF

Country where clinical trial is conducted

Norway, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Substance use outcomes measured by Europ-ASI Quality of Life		6 months after discharge	No
Secondary	Psychological distress (SCL-90-R)		6 months after discharge	No